Literature DB >> 109898

Radiation therapy in bronchogenic carcinoma.

R G Slawson, R M Scott.   

Abstract

Response of intrathoracic symptoms to thoracic irradiation was evaluated in 330 patients. Superior vena caval syndrome and hemoptysis showed the best response, with rates of 86% and 83%, respectively, compared to 73% for pain in the shoulder and arm and 60% for dyspnea and chest pain. Atelectasis showed re-expansion in only 23% of cases, but this figure increased to 57% for patients with oat-cell carcinoma. Vocal cord paralysis improved in only 6% of cases. Radiation therapy has a definite positive role in providing symptomatic relief for patients with carcinoma of the lung.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109898     DOI: 10.1148/132.1.175

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  The role of interventional pulmonary procedures in the management of post-obstructive pneumonia.

Authors:  Ravindra M Mehta; Michael Cutaia
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

2.  Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.

Authors:  M F Muers; C E Round
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

3.  New technique for treating occlusive and stenosing tumours of the trachea and main bronchi: endobronchial irradiation by high dose iridium-192 combined with laser canalisation.

Authors:  H N Macha; K Koch; M Stadler; W Schumacher; D Krumhaar
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

4.  Survival of patients with unresectable non-small cell lung cancer following 6,000 rad megavoltage radiotherapy.

Authors:  P P Kumar; R R Good; P R Hynes; S H Plantz; J E Somers; B E McAnulty; G F McCaul; S S Rogers; M A Reeves
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

5.  Quality of life survey and palliative care in lung cancer patients.

Authors:  L Zoganas; G Bablekos; M Maiwand; A Charalabopoulos; V Andronadi; A Batistatou; G Vergoulas; K Charalabopoulos
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

Review 6.  Endoscopic palliation of tracheobronchial malignancies.

Authors:  M R Hetzel; S G Smith
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

Review 7.  Malignant central airway obstruction.

Authors:  Lakshmi Mudambi; Russell Miller; George A Eapen
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

8.  Outcomes of patients with advanced non-small cell lung cancer and airway obstruction treated with photodynamic therapy and non-photodynamic therapy ablation modalities.

Authors:  Ravishankar Jayadevappa; Sumedha Chhatre; Harmik J Soukiasian; Septimiu Murgu
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

9.  A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer.

Authors:  D Ball; J Smith; J Bishop; I Olver; S Davis; P O'Brien; D Bernshaw; G Ryan; M Millward
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Palliation and life quality in lung cancer; how good are clinicians at judging treatment outcome?

Authors:  J Regan; J Yarnold; P W Jones; N T Cooke
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.